Danielle J. Doberman

ORCID: 0000-0002-1134-4146
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Palliative Care and End-of-Life Issues
  • Childhood Cancer Survivors' Quality of Life
  • Cancer survivorship and care
  • Grief, Bereavement, and Mental Health
  • Family and Patient Care in Intensive Care Units
  • Neutropenia and Cancer Infections
  • Respiratory and Cough-Related Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Healthcare Decision-Making and Restraints
  • Disaster Response and Management
  • Pain Management and Opioid Use
  • Asthma and respiratory diseases
  • Bone health and treatments
  • Patient Dignity and Privacy
  • Emergency and Acute Care Studies
  • Pharmacological Receptor Mechanisms and Effects
  • Bone health and osteoporosis research
  • Global Health Care Issues
  • Art Therapy and Mental Health
  • Education and Critical Thinking Development
  • Pediatric Pain Management Techniques
  • Geriatric Care and Nursing Homes
  • Child Therapy and Development
  • Opioid Use Disorder Treatment
  • Ethics in medical practice

Johns Hopkins University
2006-2025

Johns Hopkins Medicine
2007-2025

Johns Hopkins Hospital
2021-2024

Sidney Kimmel Comprehensive Cancer Center
2021

George Washington University Hospital
2017

George Washington University
2014-2016

Greater Baltimore Medical Center
2007

Johns Hopkins Bayview Medical Center
2006

Palliative care has evolved to be an integral part of comprehensive cancer with the goal early intervention improve quality life and patient outcomes. The NCCN Guidelines for Care provide recommendations help primary oncology team promote best possible throughout illness trajectory each cancer. Panel meets annually evaluate update based on panel members' clinical expertise emerging scientific data. These Insights summarize panel's recent discussions highlights updates importance fostering...

10.6004/jnccn.2021.0033 article EN Journal of the National Comprehensive Cancer Network 2021-07-01

We aimed to conduct a needs assessment survey better understand the frequency and types of procedures performed in across hospice educational settings order enhance education curriculum diverse practice communities. implemented distributed it leaders palliative medicine The revealed are being care these at least monthly highlights clear need for procedural skills training be integrated level.

10.1177/10499091251331214 article EN American Journal of Hospice and Palliative Medicine® 2025-03-27

Background Ethics training is essential to hospice and palliative medicine (HPM) training. Ten residencies can lead into HPM fellowship, but clinical ethics tested on board certification exams vary in content weight across specialties. Objective We reviewed EOL by from that fellowship Methods analyzed relative frequencies of categories within specialties the respective exam outlines. Results The were 28.1% Surgery; 15.6% Emergency Medicine; 12.5% Anesthesiology; Internal 9.4% Psychiatry...

10.1177/10499091251331200 article EN American Journal of Hospice and Palliative Medicine® 2025-04-02

In 2006, Medicare implemented its prescription benefit plan. Therefore, insights into medication costs at the end of life may help guide clinicians to navigate Part D coverage for chronically ill individuals.We examined drug spending by disease and demographics Medicare+Choice (M+C) beneficiaries in last year (LYOL).Retrospective review M+C decedents' claims enrollment data collected between January 1998 December 2000, supplemented denominator file 1990 Census data.Four thousand six hundred...

10.1089/jpm.2006.9.884 article EN Journal of Palliative Medicine 2006-08-01

On January 1, 2011, the Centers for Medicare and Medicaid Services (CMS) began requiring U.S. hospices to conduct a "face-to-face" (F2F) assessment of eligibility continued hospice care with patients entering their third certification period (180 days after initial enrollment). Understanding which patient populations require F2F is important evaluating impact CMS regulation gauging appropriateness 6-month prognosis criteria different groups.Retrospective program records were obtained...

10.1089/jpm.2013.0512 article EN Journal of Palliative Medicine 2014-06-17

Immunotherapy has rapidly become the mainstream treatment of multiple cancer types. Since first drug approval in 2011, we have noted a decline referrals from inpatient oncology to hospice and an increase subacute rehabilitation (SAR) facilities, possibly with aim getting strong enough for immunotherapy other promising drugs. This study explores outcomes after discharge SAR, including rates cancer-directed therapy overall survival, use.We performed electronic chart review patients discharged...

10.1200/jop.19.00044 article EN Journal of Oncology Practice 2019-08-29

Rationale: Early identification of intensive care unit (ICU) patients likely to benefit from specialist palliative could reduce the time such spend in ICU receiving inconsistent with their goals. Objectives: To evaluate real-world effects early screening for criteria a medical ICU. Methods: We performed retrospective cohort study adults admitted using causal inference approach instrumental variable analysis. The intervention consisted admissions trigger conditions and, if present, offering...

10.1513/annalsats.202407-702oc article EN Annals of the American Thoracic Society 2024-10-23

Regardless of the payer and period studied prevalence potentially inappropriate medication use in elderly ranged from 21% to 40%.To look at prescribing a group Medicare+Choice beneficiaries their last year life (LYOL) large national managed care organization.Retrospective review decedents' drug claims enrollment data collected between January 1998 December 2000, supplemented by Medicare denominator file 1990 Census data.Four thousand six hundred two organization.We analyzed relationship...

10.1089/jpm.2006.0215 article EN Journal of Palliative Medicine 2007-06-01

Cough is a common problem among cancer patients, especially lung patients. Gabapentin has been shown to be effective in reducing cough number and severity patients with idiopathic refractory cough. The authors report here the successful use of gabapentin at usual doses treat including two cancer, minimal side effects. may useful addition symptom management toolbox for palliation symptoms.

10.1080/15360288.2017.1420120 article EN Journal of Pain & Palliative Care Pharmacotherapy 2017-10-02

<h3>Outcomes</h3> 1. Through a review of exam outlines, participants will realize the lack consistency in end-of-life ethics content between residencies that lead into HPM fellowship. 2. Participants recognize relevance standardizing education across fellowship programs. <h3>Key Message</h3> Ethics training is essential to hospice and palliative medicine (HPM) training. Ten feed fellowship, but clinical tested on board certification exams vary weight specialties. Given this variance, end...

10.1016/j.jpainsymman.2024.02.147 article EN other-oa Journal of Pain and Symptom Management 2024-04-18

Abstract Rationale The Joint Commission emphasizes the importance of cultural competence and effective communication in quality medical care, particularly during end‐of‐life (EOL), when decisions are influenced by diverse religious backgrounds. For Orthodox Jewish patients, philosophical framework used for EOL decision‐making may conflict with that traditional Western ethics. In this paper, we explore complexities devout patients highlight how approaches differ from a ethical framework. Aims...

10.1111/jep.14109 article EN Journal of Evaluation in Clinical Practice 2024-08-06

241 Background: Refractory cough is a significant problem for cancer patients. Therapeutic options are suboptimal and based on low quality of evidence. Gabapentin gamma aminobutyric acid analog that may regulate neurotransmitter release via activity at the alpha-2-delta subunit voltage dependent calcium channels. It hypothesized to ameliorate through central mechanism effective in relieving chronic refractory idiopathic cough. However, gabapentin has not been studied patients with We report...

10.1200/jco.2017.35.31_suppl.241 article EN Journal of Clinical Oncology 2017-11-01

11530 Background: Immunotherapy has rapidly become mainstream treatment. Since the first drug approval in 2011, we have noted a decline referrals from inpatient oncology to hospice, and an increase sub-acute rehabilitation (SAR) facilities, possibly with aim of “getting strong enough” for immunotherapy other promising drugs. This study explores outcomes after discharge SAR, including rates cancer-directed therapy overall survival, hospice utilization. Methods: Electronic chart review...

10.1200/jco.2019.37.15_suppl.11530 article EN Journal of Clinical Oncology 2019-05-20
Coming Soon ...